Ever since the passage of the Inflation Reduction Act (IRA), which gave the Centers for Medicare and Medicaid Services (CMS) the ability to negotiate maximum fair prices (MFP) for a selected group of ...

In the wake of the Food and Drug Administration’s (FDA’s) controversial decision to approve aducanumab for Alzheimer’s disease, how will, and how should, Medicare respond? We propose a coverage with ...

Angela Palo is COO of Pinnacle Financial Services, a leading National Medicare Brokerage, and member of the NABIP Medicare FMO Council. For several years, I was the compliance officer at my agency. It ...